AI-driven innovation across health, security

AI-driven innovation is rapidly transforming various sectors, offering precise and resilient solutions to complex challenges that span from digital security to agricultural sustainability and human well-being. This macro-trend manifests as a powerful through-line that cuts across critical domains, from protecting digital infrastructures to food sustainability, up to health innovation. We are witnessing an era in which precision, enabled by advanced technologies, promises to overcome challenges that for decades resisted traditional approaches, signaling a clear direction for the future of innovation.

AI-driven innovation is rapidly transforming various sectors, delivering precise and resilient solutions to complex challenges that span from digital security to sustainable agriculture

The ability to collect, interpret, and act on massive volumes of data is crucial to defend systems from malevolent AI agents, optimize agricultural production in a changing climate, and unveil the mysteries of the human body for more effective cures. This evidence- and personalization-based approach is redefining how we tackle problems and creates new opportunities for founders and innovators. The convergence of these forces is shaping a future in which efficiency, security, and well-being are intrinsically linked to our capacity to harness the transformative potential of emerging technologies.

The scale of this transformation is tangible through several significant investments. AI cybersecurity startups have attracted $855 million in seed financing, addressing increasingly complex digital threats. Meanwhile, Wild Bio has secured €65.8 million for precision agriculture, while DITTO has raised €5.2 million for menstrual health. Finally, Throne Science secured $10 million for gut health monitoring. These are not isolated events but tiles in a larger mosaic that illustrates a clear trajectory toward a smarter, more interconnected economy and society, where health innovation serves fundamental and complex needs.

Health Innovation Driven by Necessity: AI and the New Frontier of Cybersecurity

Growing concerns about cybersecurity risks posed by AI have catalyzed an unprecedented influx of capital into the startup sector, signaling a clear direction for health innovation driven by necessity. This year, startups operating at the AI and security intersection raised a total of $855 million across more than 150 seed rounds, initial investments intended to support the development of an idea or a minimum viable product. According to Crunchbase data, this figure projects a historical record of investments. This signals deep investor confidence in the sector, foreshadowing a future in which malicious AI agents could cause digital disruptions. This concern was recently underscored by an attack by an OpenAI agent, a leading AI research and development company, on the open-source Hugging Face platform, a community for AI and machine learning.

A detailed analysis reveals robust seed-stage investment activity with rounds ranging from $5 to $10 million. This segment, often overlooked in favor of mega-deals tied to AI, has seen a wide range of companies obtain funding for diverse missions. These span from identifying AI hallucinations to building adversary simulations, to verifying agents in the financial sector. In addition, seed and early-stage rounds, investments at an initial development phase often following seed, have been recorded as well, with substantial amounts. Notable investments include Oak, which secured $60 million in a seed round for its identity intelligence technology, a system that analyzes and verifies digital identities in the AI era. Cylake, a Silicon Valley startup focused on an independent, cloud-agnostic AI-native cybersecurity platform, raised $45 million in a seed round in March. JetStream Security launched in March with a $34 million seed round for its AI governance and security platform for enterprises, aimed at managing and protecting the use of AI within organizations. These large-scale investments are often fueled by high-profile founding teams. For example, Nir Zuk of Cylake is the founder of Palo Alto Networks, a global cybersecurity leader. JetStream, meanwhile, has attracted veterans from CrowdStrike, a provider of endpoint security solutions, and SentinelOne, another cybersecurity company specialized in AI-based protection. Such profiles, combined with impressive early traction, underscore the severity and urgency perceived for this new frontier of digital security.

Wild Bio and Precision Agriculture: Food Resilience in the Climate Change Era

In the agricultural sector, technology-driven innovation is propelled by the need to secure food supplies in a context of climate change and limited resources. Wild Bioscience (Wild Bio), a agritech spin-off, technology applied to agriculture, from the University of Oxford, responded to this challenge by acquiring F1 Seed, an independent wheat breeding company based in Suffolk. This acquisition aims to create the first independent British precision wheat breeding operation, transforming Wild Bio into a fully integrated seed company in the United Kingdom. This move follows a significant Series A investment of €51 million for Wild Bio. The investment, as reported, brought the company’s total financing to €65.8 million (about $75 million), with backing from investors such as The Ellison Institute of Technology, Oxford Science Enterprises, Braavos Capital, and the University of Oxford.

Founded in 2021 by Dr. Ross Hendron and Steve Kelly, Wild Bio employs evolutionary biology, artificial intelligence, and gene editing to develop next-generation resilient crops. The company focuses on designing traits that promote higher yields and low-carbon agriculture. Its approach decodes millions of years of plant evolution to identify promising genetic improvements from wild species. These “evolutionary innovations” then guide precision breeding strategies for elite modern crop varieties. This process accelerates results that would take prohibitive time with conventional breeding. Wheat, Britain’s largest crop with an annual value of around three billion pounds, has seen its genetic diversity decline due to the dominance of foreign multinationals. This has left more than 50% of domestic varieties vulnerable to diseases such as yellow rust, a fungal disease affecting cereal crops. Wild Bio’s approach aims to reverse this trend, offering farmers precisely designed seed varieties to address challenges like drought, heat, and flooding, and to boost yield curves.

DITTO and Menstrual Health: Bridging Gaps with Research and Technology

The female health sector is witnessing a major wave of innovation, with companies like DITTO dedicated to bridging gaps in research and care in menstrual health. DITTO, a science-founded startup, announced a seed round of €5.2 million (about $6 million) in July 2026. This round was led by FoodLabs, with support from EKA Ventures and other angel investors, individuals who invest their own capital in early-stage startups in exchange for equity. The funds will accelerate its research projects, expand its lineup of scientifically supported supplements, and broaden its reach. The company, founded in 2024 by neuroscientist and nutritionist Alice van der Schoot and former L’Oréal Brand Director Adam Kugler, sits at the intersection of research, community, and targeted solutions.

DITTO addresses the reality that symptoms linked to the menstrual cycle and hormonal fluctuations have long been undervalued and under-studied, leaving many women without adequate answers. The company undertakes its own research, decodes existing studies, and combines neuroscience and nutrition to develop evidence-based products. Its first product, Premenstrual Daily, is a proactive supplement designed to act in advance. It helps the body and brain build resilience to the impacts of hormonal swings before symptoms manifest. The ingredients are selected for robust scientific backing and encapsulated with innovative technology for maximum bioavailability, i.e. the proportion of a substance that is absorbed and used by the body. DITTO has completed clinical studies on the final formulation, reporting a significant reduction in symptoms in 88% of participating women. Further large-scale real-world evidence studies are underway, with the aim of translating emerging research for a community of over 300,000 people. This science- and community-based approach is enabling many women to feel heard and supported with effective solutions for conditions like PMS and the more severe PMDD (premenstrual dysphoric disorder).

Throne Science: Gut Health Monitoring via AI and Longitudinal Data

Digestive health, a critical yet often overlooked area of human well-being, is receiving innovative attention thanks to startups like Throne Science. The company, co-founded by former Whoop CTO John Capodilupo, a wearable fitness technology company, raised $10 million in a Series A round in July 2026, led by Will Ventures. The funding brings its total capitalization to nearly $18 million since its 2023 inception. Throne Science develops an AI-powered toilet camera to monitor gut health and hydration directly from human waste.

The Throne device uses computer vision to transform raw camera data into meaningful health metrics. The company employs a pipeline of about a dozen AI vision models, some trained by practicing gastroenterologists, to analyze various features of stool and urine. A key innovation is the “Gut Health AI coach,” a beta version introduced in early July 2026, which allows users to ask questions about their data and receive personalized feedback. This tool leverages large language models (LLMs) to interact with users after episodes of gut health issues, identifying relevant factors such as stress, dietary changes, or sleep. The long-term goal is to connect the dots between diet, lifestyle, and what actually happens in the gut, turning daily readings into actionable insights. Throne Science’s Chief Product Officer John Capodilupo emphasizes that the value lies in longitudinal data, data collected from the same individual over a long period, which enables the product to “know” the user and advance science. This approach is particularly relevant for conditions like inflammatory bowel diseases (IBD), where dense longitudinal datasets on human gastrointestinal function are scarce.

The unifying element across these diverse manifestations of AI-driven innovation is the strategic use of data and artificial intelligence to tackle complex problems with unprecedented precision. Whether it is protecting digital systems from advanced AI threats, as evidenced by investments in cybersecurity, or enhancing crop resilience to climate change, as shown by Wild Bio, the ability to analyze large volumes of information and derive actionable insights is fundamental. This technological convergence not only enables the creation of more effective products and services but also opens new frontiers in research and development, especially in health-related fields. For example, Throne Science’s longitudinal data collection approach for gut health and DITTO’s research-driven approach to menstrual health share the common challenge of overcoming decades of insufficient data collection and research, using technology to bridge these gaps and deliver personalized, evidence-based solutions.

In an era where digital trust is under constant threat and environmental sustainability and personal health are under pressure, AI emerges not only as a source of new challenges but, more importantly, as a powerful enabler of solutions. The startups mentioned, from cybersecurity to agritech and femtech, demonstrate that investors are ready to bet on a future where technology, particularly AI, sits at the heart of solving humanity’s most urgent problems.

These examples illustrate a cle